TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Cannabis Stocks
Have Cannabis Stocks Totally Gone Up in Smoke?
Cannabis Stocks
Canopy Growth Stock Jumped 30% Last Month: What’s Going on?
Cannabis Stocks
These Threats Facing Canopy Growth Stock Could Justify Selling it
Investing
Canopy Growth Stock Is Down 69% Over the Past Year: Can It Ever Recover?
Stocks for Beginners
This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors
Cannabis Stocks
1 Cannabis Stock That’s My Speculative Sector Play
Cannabis Stocks
Canopy Growth: Buy, Sell, or Hold in July 2025?
Cannabis Stocks
Best Stock to Buy Right Now: Bausch Health vs Canopy Growth?
Cannabis Stocks
Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now?
Tech Stocks
Buy the Dip, Eh? 3 Canadian Stocks to Scoop Up During This Correction
Stocks for Beginners
Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?